Lung Cancer Screening & Nodule Pathways
Summarizes eligibility requirements, program infrastructure, nodule follow-up algorithms, reimbursement coding, and approach to positive screens and quality metrics.
Track your progress—Lung Cancer Screening & Nodule Pathways will stay highlighted in the catalog.
Exam mapping & scope
Mapped to the AABIP/CAQ IP domains on oncologic diagnostics and programmatic screening: eligibility, shared decision‑making, CTLS technical standards, Lung‑RADS v2022, nodule management and escalation (PET/CT, biopsy, bronchoscopy, surgery), benefits/harms (mortality, false positives, complications, radiation), special populations (COPD/ILD, cancer survivors), and evolving tools (risk models, biomarkers).
Focus this round
- Eligibility pathways
- Algorithm memorization
- Quality requirements
Orientation
Target audience: IP fellows and practicing pulmonologists Mode: Publication‑ready (clean) Length: ~2,800 words MCQs: 12
Interactive chapter
Expand sections to review focused notes. Search filters headings and body copy in real time.